






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 1-1. Interconversion among the seven known phosphoinosiƟ de lipids
Interconversion among the seven known phosphoinosiƟ de lipids occurs via acƟ on of 
specifi c lipid kinases (red arrows) and phosphatases (blue arrows). Selected kinases and 
phosphatases are shown. While controversial, direct conversion of PI to PI5P via PIK-
fyve acƟ vity may contribute to the PI5P pool (gray arrows). INPP4A phosphatase, which 
causes neurodegeneraƟ on in mice (Norris et al., 1995), and the type II PI5P 4-kinase 
(Carricaburu et al., 2003, Rameh et al., 1997), which has a role in the regulaƟ on of PI5P 
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Figure 1-2. Fab1/PIKfyve, Vac14 and Fig4 are conserved in most eukaryotes
Domains of S. cerevisiae and human Fab1/PIKfyve, Vac14 and Fig4/Sac3 are shown. 
(A) Fab1 domains include FYVE (binds PI3P), DEP (unknown funcƟ on; present in 
chordate and insect Fab1), CCT (homologous to the chaperone Cpn60/TCP-1 family; 
mediates interacƟ ons with Vac14), CCR (a conserved cysteine rich domain found only 
in Fab1/PIKfyve; part of the Vac14 binding region), kinase (catalyƟ c site for conversion 
of PI3P to PI(3,5)P2). (B) Vac14 is composed of tandem HEAT repeats, which are rod-
like helical structures that mediate protein-protein interacƟ ons. (C) Fig4 contains a Sac 
domain, which is a module found in several lipid phosphatases. Note, the number of 
amino acids in mouse PIKfyve and human PIKfyve are not idenƟ cal. The catalyƟ cally 
impaired mutaƟ on in mouse PIKfyve, K1831E, is indicated on the schemaƟ c of human 
PIKfyve, K1877E. The boundaries for FYVE, CCT, CCR, kinase, and Sac domains were 
idenƟ fi ed as follows: 1) conserved in mulƟ ple sequence alignments and 2) contained 
unbroken secondary structure elements predicted by the program Jpred. Sequences 
for Fab1/PIKfyve were from the following species: Saccharomyces cerevisiae (budding 
28
yeast, NP_116674), Schizosaccharomyces pombe (fi ssion yeast, NP_596090), Candida 
albicans (human pathogen, CAC42810), Ashbya gossypii (coƩ on pathogen, NP_985045), 
Arabidopsis thaliana (plant, NP_001078484), Drosophila melanogaster (fl y, NP_611269), 
Apis mellifera (honey bee, XP_393666), Anopheles gambiae (mosquito, XP_314118), 
CaenorhabdiƟ s elegans (worm, CAA19436), and Homo sapiens (human, NP_055855). 
The Sac domain in Fig4 was defi ned through alignment of the following Sac domain 

























Figure 1-3. SchemaƟ c of the Fab1/PIKfyve, Vac14, Fig4/Sac3 complex
Vac14 oligomerizes with itself and nucleates the complex through direct interacƟ ons 
with Fab1/PIKfyve and Fig4/Sac3. In yeast, Vac14 also directly interacts with Atg18 and 
Vac7. The yeast Vac14 point mutants, H56Y (HEAT repeat loop 2), R61K (HEAT repeat 
loop 2) and Q101R (HEAT repeats loop 3), each disrupt binding of Atg18 and Vac7. Thus, 
Atg18 and Vac7 may bind overlapping or idenƟ cal sites of Vac14 (Jin et al., 2008). The 
Vac14-L156R mutaƟ on, found in ingls mice, and corresponding mutaƟ on Vac14-L149R 
in yeast, disrupts Vac14 interacƟ on with Atg18, Vac7 and Fab1. This suggests that all 
three proteins bind overlapping sites on Vac14. The point mutaƟ on, Fig4-I41T found in 
paƟ ents with CMT4J, disrupts the interacƟ on between Fig4 and Vac14, although the 
major porƟ on of human Fig4 that interacts with Vac14 resides within residues 478-907 
(Ikonomov et al., 2009b). In mammalian cells, myotubularin related proteins (MTMRs) 
can convert PI(3,5)P2 to PI5P and may provide the majority of cellular PI5P. ◊This fi gure is 



























































Figure 1-4. Cellular localizaƟ on of PI(3,5)P2
(A) LocalizaƟ on of PI(3,5)P2 and PI5P inferred from the localizaƟ on of PIKfyve and Vac14. 
PI(3,5)P2 localizes on early endosomes, late endosomes and lysosomes. LocalizaƟ on of  
PI(3,5)P2 on autophagosomes is less clear. PI5P may also be present at all or some of 
these locaƟ ons. To further establish the locaƟ ons of these lipids, suitable lipid probes 
need to be developed. PI(3,5)P2 eﬀ ectors and traﬃ  cking pathways aﬀ ected in PIKfyve/
Vac14/Fig4 defi cient cells are also indicated. Purple: known PI(3,5)P2 eﬀ ectors. Blue: 
proteins aﬀ ected by PI(3,5)P2 and/or PI5P. (B) The size of a yeast vacuole or mammalian 
lysosome is dependent on ion and water homeostasis, as well as the net sum of 












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 2-1. VAC14 is widely distributed in all Ɵ ssues and brain regions tested
(A) Polyclonal rabbit anƟ -VAC14 anƟ body specifi cally recognizes VAC14 on western blots. 
Brain extracts from P0 wild-type and Vac14-/- pups were homogenized and detected by 
western blot analysis using anƟ -VAC14. (B) VAC14 is expressed in all Ɵ ssues tested. Brain, 
heart, lung, liver and kidney were dissected from P0 pups. Western blots were probed 
with aﬃ  nity purifi ed rabbit anƟ -VAC14 anƟ body. (C) VAC14 is found in all tested regions 
of the brain. (B-C) Vac14-/- liƩ er mates indicate the absence of VAC14 in all Vac14-/- 
Ɵ ssues. Blots shown are representaƟ ve of 3 independent experiments. VAC14 expression 
levels were quanƟ fi ed using the raƟ o of VAC14/GAPDH band densiƟ es and normalized to 
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Figure 2-2. Vacuoles in cultured Vac14-/- hippocampal neurons
(A) Vac14-/- neurons form vacuoles as early as 1 DIV. StarƟ ng from 12 DIV, vacuoles 
were frequently observed in both the soma and the neurites (arrows). (B) Wild-type 
and Vac14-/- neurons were fi xed and labeled with LAMP1 or EEA1. Vacuoles in Vac14-/- 
neurons (arrows) are posiƟ ve for LAMP1 (late endosomal and lysosomal marker) but not 
EEA1 (early endosomal marker). (C) VacuolaƟ on in neurons is not rescued by suppressing 
neuronal acƟ viƟ es. Hippocampal neurons from wild type or Vac14-/- embryos were 
treated with 2 μM TTX, 20 μM APV and 40 μM CNQX starƟ ng from 3 DIV. Media were 
changed every other day in both drug treated and control dishes. Neurons were imaged 
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Figure 2-3. Vac14-/- neurons form vacuoles in culture, yet arborizaƟ on is similar to wild-
type neurons
(A) Examples of Stage I-V hippocampal neurons. Hippocampal neurons start out as 
fi broblast-like lamellipodia (Stage I). Then several short neurites emerge (Stage II). One 
extends further than the others and commits to the fate of an axon (Stage III). The other 
neurites (dendrites) extend further and form complicated networks (Stage IV &V). Bar = 
10 μm. (B) Vac14-/- neurons undergo normal arborizaƟ on. Cultured wild-type and Vac14-
/- neurons were plated at a density that allowed visualizaƟ on of single neurons (5, 000 to 
10, 000 per 1.91 cm2), and randomly selected neurons were imaged every 24h by phase 
contrast microscope. The numbers of neurons at diﬀ erent stages were counted. N = 50-
80 neurons for each. Similar results were obtained in three independent experiments. 
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Figure 2-4. Endogenous VAC14 parƟ ally colocalizes with mulƟ ple endocyƟ c organelles
(A) Polyclonal VAC14 anƟ body recognizes punctate structures in wild-type cells. 
Fibroblasts were permeabilized with saponin followed by fi xaƟ on and labeled with 
anƟ -VAC14 anƟ body. BoƩ om panels, DIC images. (B) In fi broblasts, endogenous VAC14 
colocalizes with both EEA1 and LAMP1. Wild-type fi broblasts were triple labeled 
with rabbit anƟ -VAC14, chicken anƟ -EEA1 and rat anƟ -LAMP1. The majority of VAC14 
colocalized with either EEA1 (yellow arrows) or LAMP1 (turquoise arrows). Some VAC14 
colocalized with both (white arrows) or neither (green arrow) markers. (C) VAC14 
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parƟ ally colocalizes with the late endosome marker LBPA (arrow). Fibroblasts are double 
labeled with rabbit anƟ -VAC14 and mouse anƟ -LBPA. (D) VAC14 parƟ ally colocalizes 
with lysosomes (arrow). To label lysosomes, prior to fi xaƟ on, fi broblasts were pulsed 
with Texas Red-Dextran (MW 70kD) for 1 hour and chased in the absence of dextran for 
24 hours. (E) The limiƟ ng membrane of vacuoles in Vac14-/- cells is posiƟ ve for LAMP1 
while negaƟ ve for LBPA (arrow), suggesƟ ng a lysosomal origin. Vac14-/- fi broblasts were 
double labeled with rat anƟ -LAMP1 and mouse anƟ -LBPA. (D-E) DAPI (blue) was used to 
label the nuclei. (F) VAC14 parƟ ally colocalizes with LC3-RFP puncta (arrows). Fibroblasts 
transfected with LC3-RFP were fi xed and labeled with anƟ -VAC14. (A-F) Bar = 10 μm. 
◊Data in A-E were collected and analyzed by Yanling Zhang. Data in F were collected and 
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Figure 2-5. Polyclonal rabbit anƟ -VAC14 anƟ body specifi cally recognizes VAC14 in fi xed 
cells
(A) Immunofl uorescence with anƟ -VAC14. Puncta in the cytoplasm were seen in wild-
type cells but not Vac14-/- cells. Nonspecifi c nuclear staining was frequently present in 
cells cultured from both wild-type and Vac14-/- mutant mice. BoƩ om panels, DIC images. 
(B, C, D, E) Vac14-/- controls for Figure 2-8 B, C, D, F, respecƟ vely. Bar = 10 μm. (F-G) 
QuanƟ fi caƟ on of VAC14 colocalizaƟ on with endocyƟ c and autophagic markers. 
(F) Percentages of VAC14 puncta that colocalized with EEA1, LAMP1, neither 
marker or both markers were quanƟ fi ed from triple labeling of VAC14/EEA1/LAMP1 
immunofl uorescence (N = 11 cells). Error, STD. (G) Percentages of VAC14 puncta that 
colocalized with LBPA, Dextran or LC3 were quanƟ fi ed from double labeling of VAC14 
and the marker of interest (N= 7 for LBPA, 16 for Dextran, 15 for LC3). Error bars, STD. 
◊Data in A-D were collected and analyzed by Yanling Zhang. Data in E were collected and 













Figure 2-6. VAC14 distribuƟ on in the endomembrane system
Diagram of proposed PI(3,5)P2¬ distribuƟ on in the endomembrane system. Based on 
the localizaƟ on of endogenous VAC14, PI(3,5)P2 localizes on early endosomes, late 
endosomes, lysosomes, and possibly autophagosomes. CCV, clathrin coated vesicles; EE, 
early endosomes; LE, late endosomes, RE, recycling endosomes; AP, autophagosomes; 










Figure 2-7. VAC14 parƟ ally colocalizes with EEA1 or LAMP2 in the soma
Wild-type and Vac14-/- neurons were double labeled with rabbit anƟ -VAC14 and chicken 
anƟ -EEA1 (A) or rat anƟ -LAMP1 (B). Arrows; colocalizaƟ on between VAC14 and EEA1 or 















Figure 2-8. VAC14 is found in both dendrites and axons, and colocalized with endocyƟ c 
and synapƟ c markers in hippocampal neurons
(A) Wild-type and Vac14-/- neurons were double labeled with rabbit anƟ -VAC14 
and mouse anƟ -MAP2 (dendrites) or mouse anƟ -TAU-1 (axons). Arrows indicate 
the localizaƟ on of VAC14 on dendrites (MAP2 posiƟ ve and TAU negaƟ ve neurites). 
Arrowheads indicate the localizaƟ on of VAC14 on axons (MAP2 negaƟ ve and TAU-1 
posiƟ ve neurites). Bar = 10 μm. (B) VAC14 parƟ ally colocalizes with EEA1 or LAMP1 in 
the neurites (arrows). Wild-type and Vac14-/- neurons were triple labeled with rabbit 
anƟ -VAC14, chicken anƟ -EEA1 and rat anƟ -LAMP1. Bar = 5 μm. (C) VAC14 displays 
signifi cant colocalizaƟ on with several synapƟ c markers: synapsin, synaptotagmin 
and synaptobrevin. Wild-type and Vac14-/- neurons were double labeled with rabbit 
anƟ -VAC14 and guinea pig anƟ -synapsin, mouse anƟ -synaptotagmin or mouse anƟ -
synaptobrevin. Bar = 5 μm. (D) VAC14 parƟ ally localizes at excitatory synapses (labeled 
with both the synapƟ c vesicle glutamate transporter vGlut1, and postsynapƟ c marker 
PSD95). Wild-type and Vac14-/- neurons were labeled with rabbit anƟ -VAC14, mouse 
anƟ -PSD95 and guinea pig anƟ -vGlut1. Arrows indicate examples of colocalizaƟ on. (C 
and D) Lower panels show straightened dendrites from corresponding top panels. Bar = 




























Figure 2-9. Polyclonal rabbit anƟ -VAC14 anƟ body specifi cally recognizes VAC14 in fi xed 
neurons
(A-B) Vac14-/- controls for Figure 2-8(A-B) respecƟ vely. (C) QuanƟ fi caƟ on of VAC14 
puncta colocalizaƟ on with endocyƟ c markers in neurites. Percentages of VAC14 puncta 
that colocalized with EEA1 and LAMP1 were quanƟ fi ed from triple labeling of VAC14/
EEA1/LAMP1 immunofl uorescence (N = 12 neurites). Error, STD. (D-E) Vac14-/- controls 
for Figure 2-8(C-D), respecƟ vely. (A) Bar = 10 μm. (B, D, E) Bar = 5 μm. ◊Data in A-D were 


















































































Figure 2-10. Loss of VAC14 or FIG4 leads to an increase in excitatory synapƟ c funcƟ on
(A) RepresentaƟ ve mEPSC recordings of wild-type (N=32) and Vac14-/- neurons (N=32). 
(B) Mean mEPSC amplitude in Vac14-/- neurons is larger than wild-type neurons, 
20.86±1.03 pA vs. 16.83±0.91 pA, respecƟ vely. *p = 0.0045, t-test. (C) Mean mEPSC 
frequency is similar in wild-type (1.21±0.26 Hz) and Vac14-/- (1.16±0.24 Hz) neurons. 
(D-E) Summary of mEPSC kineƟ cs in wild-type and Vac14-/- neurons. (D) Individual 
mEPSCs overlaid. Thick lines show the mean trace. Dashed line is aligned to the mean 
peak inward current of Vac14-/- mEPSC. Scaled overlay shows similar kineƟ cs between 
wild-type and Vac14-/- mEPSCs. (E) Mean mEPSC decay is similar between wild-type 
(3.80±0.15 ms) and Vac14-/- (3.69±0.14 ms). (F) RepresentaƟ ve mEPSC traces of wild-
type (Fig4+/+) (N=12) and Fig4-/- neurons (N=14).  (G) Mean mEPSC amplitude in Fig4-
/- neurons is larger than Fig4+/+ neurons (14.64±0.39 pA vs. 18.73±1.38 pA, respecƟ vely. 
*p =0.0164, t-test). (H) Mean mEPSC frequency is similar in Fig4+/+ and Fig4-/- (0.99±0.22 







































































































































Figure 2-11. PresynapƟ c probability of release is enhanced in Vac14-/- neurons
(A-B) SynapƟ c vesicles from Vac14-/- are not larger than synapƟ c vesicles observed 
in brains from wild-type. (A) Electron microscopy of excitatory synapses, evident by 
the thickening of the postsynapƟ c membrane, in wild-type and Vac14-/- hippocampus 
and hindbrain. Bar = 100 nm. (B) QuanƟ fi caƟ on of the diameter of synapƟ c vesicles. 
CumulaƟ ve probability distribuƟ on of synapƟ c vesicle diameter. No signifi cance 
diﬀ erence was found between wild-type and Vac14-/- by a two-sample Kolmogorov-
Smirnov test (kstest2, Matlab) (hippocampus, p=0.32; hindbrain, p=0.46). Three wild-
type and three Vac14-/- animals were analyzed. Hindbrain: N = 567 vesicles from 33 
terminals for wild-type and 388 vesicles from 29 terminals for Vac14-/-. Hippocampus: 
N = 433 vesicles from 33 terminals for wild-type and 66 vesicles from 15 terminals for 
Vac14-/-. (C-D) The number of synapses is decreased in Vac14-/- neurons. (C) Wild-type 
and Vac14-/- hippocampal neurons were triple labeled with rabbit anƟ -MAP2 (blue), 
mouse anƟ -PSD95 (red) and guinea pig anƟ -vGlut (green). Examples of straightened 
dendrites are shown. Bar = 5 μm. (D) QuanƟ taƟ on of the number of synapses on the fi rst 
100 μm of dendrites starƟ ng from the soma. The numbers of synapses were normalized 
to the average of wild-type. Vac14-/- neurons had fewer synapses (N = 91 for wild-type 
and 71 for Vac14-/-) (*p = 1.7 x 10-4, t-test). Error bars, SEM. (E-F) PresynapƟ c probability 
of release is increased in Vac14-/- neurons. NMDA currents were pharmacologically 
isolated from AMPA and GABAA mediated currents and recorded at -70 mV (soluƟ on 
contained 0 Mg2+). An extracellular sƟ mulaƟ ng electrode was placed locally and used to 
sƟ mulate vesicle release in aﬀ erent axons. Once a stable response was obtained, 20 μM 
MK801, an open-channel blocker of NMDA receptors, was added to the bath for 5 mins 
without sƟ mulaƟ on. Then 200 sƟ mulaƟ ons were delivered and amplitude of the current 
measured (mean amplitude is shown by fi lled circles). In the presence of MK-801, the 
current is progressively blocked. The data for each genotype were fi Ʃ ed with a double 
exponenƟ al curve. The rate of progressive blockade of NMDA current was signifi cantly 
greater in Vac14-/- neurons; mean amplitude of the 2-11 sƟ mulaƟ ons is signifi cantly 
lower in Vac14-/- neurons. *p=0.0217, Anova1 (Matlab). ◊Data in A were collected by 















































Figure 2-12. RestoraƟ on of VAC14 eliminates the increase in mEPSC amplitude in 
Vac14-/- neurons
(A) Examples of mEPSC recordings of wild-type and Vac14-/- neurons that were sham-
transfected, expressed VAC14-Citrine or Citrine alone. (B) QuanƟ fi caƟ on of mEPSC 
amplitude normalized to sham-transfected wild-type neurons shows that there is 
an inverse relaƟ onship between level of VAC14 expression and mEPSC amplitude. 
In wild-type neurons, VAC14 overexpression decreases amplitude. The increase in 
mEPSC amplitude in Vac14-/- neurons is reduced by reintroducƟ on of VAC14. Neurons 
transfected with Citrine were similar to untransfected wild-type. One-way ANOVA test 
was used to compare mEPSC amplitudes (p=8.27e-9). *Individual comparisons were 
determined using the Tukey-Kramer post hoc. WT, wild-type; KO, Vac14-/-; Cit, Citrine. 
Error bars, SEM.
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Figure 2-13. Total expression of GluA2 is similar
Cultured hippocampal neurons at 14 DIV were collected, lysed and total protein 
separated by SDS-PAGE. To confi rm linearity of the assay, a series of diluƟ ons of WT 
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Figure 2-14. Surface GluA2 levels increase in Vac14-/- neurons
(A) Surface GluA2 was labeled by incubaƟ on of intact neurons with mouse anƟ -GluA2 
anƟ body. Arrows highlight the dendrite used for analysis (enlarged in lower panels). 
Intensity presented in the “fi re” LUT color scheme. (B) QuanƟ taƟ on of the intensity of 
GluA2 puncta, normalized to the wild-type mean. The relaƟ ve intensity values from wild-
type and Vac14-/- neurons are presented as a cumulaƟ ve distribuƟ on. A Kolmogorov-
Smirnov test demonstrates that the data sets diﬀ er signifi cantly (p = 1.1e-34). The 
median of each data set also diﬀ er signifi cantly (box plot in insert). Box, interquarƟ le 
range; line, median; square, mean; non-overlapping notches indicate that the two 
medians are staƟ sƟ cally diﬀ erent at the 5% signifi cance level; whiskers, minimum and 
maximum of the data within 1.5 Ɵ mes the length of the box. N = 5272 for wild-type 
and 4756 for Vac14-/-. Error bars, SEM. (C) Surface GluA2 subunits accumulate on the 
surface of Vac14-/- dendrites. Top panel shows wild-type surface GluA2, total GluA2, and 
dendriƟ c marker, MAP2. Middle shows the same staining in Vac14-/- neurons. Yellow 
arrow highlights the dendrite used for analysis. BoƩ om shows the merged image of the 
straightened dendrite (leŌ ) and MAP2 (right). (D) The raƟ o of surface to total GluA2 
is increased in Vac14-/- dendrites (1.32±0.052) relaƟ ve to wild-type (1.0±0.0364). * p = 




















































































Figure 2-15. GluA2 endocytosis is reduced in Vac14-/- hippocampal neurons
(A) Diagram of experimental procedures. Wild-type or Vac14-/- hippocampal neurons 
embryos were treated with lysosomal inhibitor leupepƟ n before live labeled with mouse 
GluA2 anƟ bodies. Endocytosis was sƟ mulated with 50 μM NMDA for 10 minutes. Surface 
bound GluA2 anƟ bodies were acid stripped. Neurons were then fi xed and labeled with 
Alexa 555 anƟ -mouse IgG. (B) Example of internalized GluA2. Intensity presented in 
the “fi re” LUT color scheme. Bar = 10 μm. (C) Total internalized GluA2 in the soma was 
decreased in Vac14-/- neurons (N= 55 for wild-type and 42 for Vac14-/-. p = 2.73 x 10-5. 
t-test.) (D) Total internalized GluA2 in the dendrites was decreased in Vac14-/- neurons 
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(N= 57 for wild-type and 61 for Vac14-/-. p = 8.33 x 10-5. t-test). (E) The number of 
internalized GluA2 was decreased in Vac14-/- neurons (N= 57 for wild-type and 61 for 
Vac14-/-. p = 5.91 x 10-8. t-test.). A fi xed length (35 μm from the soma) was used for 












































Figure 2-16. Internalized GluA2 enters the degradaƟ on pathway normally in Vac14-/-
A-B) Hippocampal neurons from wild type or Vac14-/- embryos were treated with 
lysosomal inhibitor leupepƟ n before live labeled with GluA2 anƟ bodies. Endocytosis 
was sƟ mulated with 50 μM NMDA for 10 minutes. Surface bound GluA2 anƟ bodies 
were acid stripped. Neurons were then fi xed and labeled with LAMP1 anƟ bodies. C) The 
percentage of internalized GluA2 puncta that colocalized with LAMP1 was calculated 
from a fi xed length of apical dendrites (the fi rst 35 μm dendrites from soma) (N = 57 for 





















































































































































































Figure 2-17. Endocytosis of AMPA receptors is reduced in Vac14-/- neurons
Cultured hippocampal neurons were transfected with pH-GluA1and mCherry at DIV12. 
At DIV14, neurons were sƟ mulated with 20 μM NMDA for 5 mins and pH-GluA1 
intensity was monitored. (A) RepresentaƟ ve full-frame images of wild-type and Vac14-
/- neurons during baseline (0-10 mins), NMDA sƟ mulaƟ on (11-15 mins), and recovery 
aŌ er wash out (16-55 mins). (B) Changes in pH-GluA1 fl uorescence were calculated 
from straightened dendrites isolated from full-frame images. (C) Wild-type and Vac14-
99
/- neurons recovered back to baseline levels similarly. (D) Average Ɵ me-course for 
percent change in pH-GluA1 fl uorescence, normalized to average baseline intensity. (E) 
Amplitude of change in fl uorescence aŌ er wash-out of NMDA is decreased in Vac14-/- 
neurons compared to wild-type (wild-type, 66.72±4.93%; Vac14-/- 44.68±7.10%). (F) t1/2 







































Figure 2-18. Model of traﬃ  cking defects that promote the elevaƟ on of surface AMPA 
receptors in Vac14-/- neurons
Endocytosis of surface GluA2 may be reduced in Vac14-/- compared with wild-type 
neurons (1), while recycling of internal GluA2 to the cell surface (2) and membrane 
transport late in the endocyƟ c pathway (3) are normal in Vac14-/- neurons. Note that, in 
the absence of VAC14, FIG4 is destabilized (Lenk et al., 2011). V, endocyƟ c vesicles; EE, 































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3-1. Loss of PI(3,5)P2 synthesis increases synapƟ c strength and prevents 
homeostaƟ c synapƟ c downscaling
(A) SchemaƟ c of the PI(3,5)P2 synthesis complex. Vac14 is a scaﬀ olding protein that 
interacts with PIKfyve, the sole PI3P 5-kinase, and Fig4, a PI(3,5)P2 5-phosphatase and 
posiƟ ve regulator of PIKfyve acƟ vity. PI(3,5)P2 can be converted to PI3P or PI5P. In yeast, 
addiƟ onal proteins have been idenƟ fi ed in the complex, which regulate PIKfyve (in yeast, 
Fab1) acƟ vity, suggesƟ ng there are likely addiƟ onal complex members in metazoans, 
as well. (B) RepresentaƟ ve example recordings from wild-type and Vac14-/- mouse 
hippocampal cultured neurons treated for 24 h with vehicle control, 2 μM TTX or 50 
μM bicuculline (Bic). (C) Mean (±standard error of the mean (SEM)) mEPSC amplitude 
in wild-type and Vac14-/- neurons. The amplitude of Vac14-/- mEPSCs is increased 
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relaƟ ve to wild-type (wild-type: 15.16 ±0.39 pA; Vac14-/-: 19.12±0.88 pA; t(43)=31.04, 
p=4.45e-31). (D) CumulaƟ ve distribuƟ on frequency of mEPSC amplitude from wild-
type (leŌ ) and Vac14-/- (right) neurons treated for 24 h with vehicle control (black line), 
2 μM TTX (gray line) or 50 μM Bic (green line). In wild-type neurons, the distribuƟ on 
of mEPSC amplitude is leŌ -shiŌ ed following 24h bicuculline and right-shiŌ ed following 
24h TTX. While Vac14-/- neurons normally scale-up mEPSC amplitude in response to 
24 TTX, they fail to scale-down. All six distribuƟ ons were compared using the one-way 
Kruskal-Wallis ANOVA (χ2(5, n=4016)=411.56, p=9.56e-87) and the results of Tukey-
Kramer post hoc test reported here: wild-type+bicuculline is diﬀ erent from every 
group. Wild-type+TTX is diﬀ erent than WT. Vac14-/-+TTX is diﬀ erent from every group. 
WT control is diﬀ erent from Vac14-/- control. Mean (±SEM) percent change in mEPSC 
amplitude relaƟ ve to unsƟ mulated controls of the corresponding genotype. In wild-type 
neurons, 24 h treatment with TTX increases mEPSC amplitude and 24 h treatment with 
bicuculline decreases mEPSC amplitude (wild-type, percent change from control (n=24): 
+TTX: 28.79±6.99%, n=7; +Bic: -11.11±2.97%, n=23; one-way ANOVA, F(2,51)=21.41, 
p=1.775e-7). In Vac14-/- neurons, 24 h treatment with TTX increases mEPSC amplitude, 
but 24 h treatment with bicuculline does not decrease mEPSC amplitude (Vac14-/-, 
percent change from control (n=20): +TTX: 24.28±8.99%, n=7; +Bic:13.72±6.03%, n=20; 
one-way ANOVA, F(2,45)=4.06, p=0.02). (E) RepresentaƟ ve mEPSC recordings from wild-
type mouse neurons one week aŌ er lenƟ viral transducƟ on with vehicle control (sham), 
non-targeƟ ng control shRNA or PIKfyve shRNA. (F) Mean (±SEM) mEPSC amplitude in 
neurons treated or untreated with PIKfyve shRNA for 1 week. Knocking down PIKfyve 
increased mEPSC amplitude (sham: 12.73±0.40 pA; control shRNA: 11.63±0.35 pA; 
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Figure 3-2. Enhancing neuronal PI(3,5)P2 levels reduces synapƟ c depression 
(A) RepresentaƟ ve Western blots depicƟ ng Doxycycline dependent inducƟ on of 3X-FLAG 
control, 3X-FLAG-Citrine-PIKfyve (top) or 3X-FLAG-Citrine-PIKfyveKYA (boƩ om) in stable 
cell lines (HEK-293). Cells were induced for 0, 8, or 24 h before lysis and analyzed by 
Western blot. Immunobloƫ  ng for PIKfyve with an amino-terminal PIKfyve anƟ body 
reveals two bands, which is consistent with detecƟ on of endogenous PIKfyve and 
3X-FLAG-Citrine-PIKfyve or 3X-FLAG-Citrine-PIKfyveKYA. (B) Mean (±SEM) PIP levels 
relaƟ ve to total PI from 3xFLAG, 3X-FLAG-Citrine-PIKfyve and 3X-FLAG-Citrine-PIKfyveKYA 
cells. InducƟ on of 3X-FLAG-Citrine-PIKfyveKYA for 24 h increases PI(3,5)P2 and PI5P levels 
( PI(3,5)P2: 3XFLAG: 0.022±0.001%, 3XFLAG-Citrine-PIKfyve: 0.025±0.002%, 3XFLAG-
Citrine-PIKfyveKYA: 0.093±0.005%, one-way ANOVA, F(2,7)=105.44, p=5.9e-06). (PI5P: 
3XFLAG: 0.102±0.011%, 3XFLAG-Citrine-PIKfyve: 0.082±0.011%, 3XFLAG-Citrine-
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PIKfyveKYA: 0.185±0.012%, one-way ANOVA, F(2,7)=21.63, p=0.001). (C) Domain structure 
of human PIKfyve (reviewed in (McCartney et al., 2014)). Domains shown: FYVE (binds 
PI3P), DEP (funcƟ on unknown), CCT (homologous to the chaperone Cpn60/TCP-1 family), 
CCR (conserved cysteine rich domain), and kinase (catalyƟ c site for conversion of PI3P 
to PI(3,5,)P2). MulƟ ple alignment of human (Homo sapiens, AAR19397.1), fi sh (Danio 
rerio, NP_001120777.1), lancelet (Branchiostoma fl oridae, XP_002598618.1), acorn 
worm (Saccoglossus kowalevskii, XP_006821423.1); fl y (Drosophila pseudoobscura, 
XP_001361784); yeast (Saccharomyces cerevisiae, BAA09258.1). PIKfyve homologues 
with conserved amino acids shaded in teal and conservaƟ ve subsƟ tuƟ ons shaded 
in pink. Boxes indicate the mutated amino acids (E1620K, N1620K, S2068A) in the 
PIKfyveKYA mutant. (D) SchemaƟ c depicts a transfected neuron surrounded by 
nontransfected neighbors. RepresentaƟ ve recordings from cultured rat hippocampal 
neurons (DIV21) transfected at DIV14 with Citrine-PIKfyve or Citrine-PIKfyveKYA. 
Nontransfected control neurons from the same dish were also analyzed. (E) Mean 
(±SEM) mEPSC amplitude of nontransfected and transfected neurons expressing 
Citrine-PIKfyve or Citrine-PIKfyveKYA. PIKfyveKYA expression decreased mEPSC amplitude 
(uninfected: 17.75±0.78 pA; Citrine-PIKfyve: 17.14±1.16 pA; Citrine-PIKfyveKYA: 
12.65±0.43 pA; one-way ANOVA, F(2,31)=17.32, p= 0.0005). *indicates p<0.05.◊Data in A 




PI3P 0.206 ± 0.0080.191 ± 0.011
PI4P 16.590 ± 1.2743.276 ± 0.136
PI5P 0.361 ± 0.0270.306 ± 0.013
PI(3,5)P2 0.018 ± 0.0020.042 ± 0.003
PI(4,5)P2 13.188 ± 0.6084.963 ± 0.251











































Figure 3-3. Comparison of PIP levels in mouse embryonic fi broblasts and cultured hip-
pocampal rat neurons. The values for MEF cell PIP levels are from (Zolov et al., 2012).
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Figure 3-4. AcƟ vity-dependent regulaƟ on of neuronal phosphoinosiƟ de dynamics
(A) SchemaƟ c of experimental design. Neurons were metabolically labeled with [3H]-
inositol for 24 h. The media was replaced with HBS. AŌ er 5 min, HBS was replaced with 
HBS+ 2 μM TTX for 10 min, 50 μM bicuculline for 1 min or 20 μM NMDA for 1 min, and 
then lipids were extracted. For each experiment, unsƟ mulated controls (5 min HBS) 
were also collected. (B) Mean (±SEM) PIP level aŌ er sƟ mulaƟ on with TTX, bicuculline or 
NMDA expressed as percent of control (5 min HBS). The level of PI(3,5)P2 signifi cantly 
increased aŌ er 1 min NMDA sƟ mulaƟ on (Percent of control: control, 100±14.15 %, n=8; 






































































































































Figure 3-5. PI(3,5)P2 synthesis accompanies homeostaƟ c synapƟ c downscaling
(A) SchemaƟ c of experimental design. Neurons were metabolically labeled with [3H]-
inositol for 24 h in presence of DMSO control, 2 μM TTX or 50 μM bicuculline, and lipids 
were extracted. The mean (±SEM) PIP level in control neurons expressed relaƟ ve to PI. 
PIP species are ploƩ ed in order of descending abundance (PI4P: 16.95±0.56%; PI(4,5)
P2: 13.98±0.68%; PI5P: 0.38±0.04%; PI3P: 0.20±0.006%; PI(3,4,5)P3: 0.027±0.004%; 
PI(3,5)P2: 0.016±0.001%). (B) Mean (±SEM) percent change in PIP levels relaƟ ve to 
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control from neurons incubated with 2 μM TTX (n=5) or 50 μM bicuculline (n=4) for 
24 hr. The level of PI4P decreased aŌ er 24 h TTX (percent change:-21.26±1.77%, one-
way ANOVA, F(2,11)=15.2, p=0.0007). The level of PI(4,5)P2 decreased aŌ er 24h TTX 
(percent change:-15.34±2.45%, one-way ANOVA, F(2,11)=6.54, p=0.014). The level of 
PI(3,5)P2 increased aŌ er 24 h bicuculline (percent change: 60.49±16.05%, one-way 
ANOVA, F(2,11)=7.13, p=0.01). (C) RepresentaƟ ve images of neurons expressing both 
the PI(3,5)P2 reporter, mCherry-ML1N*2 and GFP. (D) Mean (±SEM) raƟ o of dendriƟ c to 
soma mCherry-ML1N*2 fl uorescence. The dendriƟ c to soma raƟ o of mCherry-ML1N*2 
intensity increased aŌ er 24 h bicuculline (Control: 1.0±0.04; 24 h Bic: 1.30 ±0.06; t-test, 
t(63)=4.12, p=0.0001). *indicates p<0.05. 
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Figure 3-6. Rapid, but transient, PI(3,5)P2 synthesis accompanies LTD inducƟ on
(A) SchemaƟ c of experimental design. PIP levels were analyzed aŌ er 24 h metabolic 
labeling, during cLTD inducƟ on (20 μM NMDA, 1 μM glycine, 0.2 mM Mg2+) or aŌ er 
inducƟ on at the specifi c Ɵ me points (30 sec, 1 min, 2 min, 3 min, 5 min, 15 min, or 35 
min). Sham treated samples were treated idenƟ cally to cLTD sƟ mulated neurons, except 
NMDA and glycine were not included in the sƟ mulus buﬀ er. (B) Mean (±SEM) PIP levels 
at Ɵ me point 0. (C) Mean (±SEM) levels of each PIP normalized to Ɵ me point 0 (dashed 
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Figure 3-7. Apilimod inhibiƟ on PI(3,5)P2 synthesis
(A) Mean (±standard deviaƟ on) PIP levels in mouse primary fi broblasts aŌ er incubaƟ on 
with 1 μM apilimod for the Ɵ mes indicated. 1 μM apilimod results in a rapid depleƟ on of 
PI(3,5)P2 and PI5P (n=3). Note, PI(3,4,5)P3 levels were not aﬀ ected by PIKfyve inhibiƟ on 
using 1 μM apilimod (Appendix I: Figure A-9).(B) Mean (±SEM) intensity of PSD-95 
puncta. PSD95 intensity is not aﬀ ected by 50 μM bicuculline, 1 h PIKfyve inhibiƟ on with 
either 2 μM YM201636 or 1 μM apilimod. (C) Mean (±SEM) intensity of surface GluA2 
puncta. InhibiƟ on with 2 μM YM201636, but not 1 μM apilimod, for 1 h increased the 
surface levels of GluA2 (control: 100±2.24%, 1 h YM201636: 130±93%, 1 h apilimod: 
95.49±2.50%; one-way ANOVA, F(2,145)=26.12, p = 1.6e-10). *indicates p<0.05. ◊Data in 
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Figure 3-8. PIKfyve acƟ vity is required for synapƟ c depression
(A) RepresentaƟ ve recording of mEPSCs from rat cultured hippocampal neurons that 
were incubated with cLTD inducƟ on, or sham soluƟ on, in the presence or absence of 
PIKfyve inhibitors. AŌ er sƟ mulaƟ on, neurons were incubated with reserved condiƟ oned 
media without PIKfyve inhibitors for 30 min at 37°C. (B) Mean (±SEM) mEPSC amplitude 
from neurons sƟ mulated with sham or cLTD inducƟ on soluƟ on in the presence of 
absence of 1 μM apilimod or 2 μM YM201636. The inducƟ on of cLTD decreased in 
mEPSC amplitude. This decrease was blocked by incubaƟ on with 1 μM apilimod or 
2 μM YM201636 during inducƟ on (Control: 17.52±0.55 pA ; cLTD: 14.72±0.53 pA; 
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cLTD+YM201636: 18.83±0.71 pA; cLTD+apilimod: 17.86±0.30 pA; 7.5min YM201636: 
19.11±0.37 pA; 7.5 min apilimod: 16.72±0.48 pA; one-way ANOVA, F(5,109)=9.77, 
p=9.8x10-8). (C) RepresentaƟ ve recordings of mEPSCs from rat cultured hippocampal 
neurons treated or untreated with 50 μM bicuculline for 24 h. AŌ er 23 h, the PIKfyve 
inhibitors, apilimod and YM201636, were added to the media of indicated dishes for 
1 h. (D) Mean (±SEM) mEPSC amplitude. Treatment with 50 μM bicuculline for 24 h 
decreases mEPSC amplitude. ApplicaƟ on of 1 μM apilimod or 2 μM YM201636 for 1 hr 
does not aﬀ ect the amplitude of mEPSCs in control neurons not treated with bicuculline. 
ApplicaƟ on of 1 μM apilimod or 2 μM YM201636 for 1 h in bicuculline treated 
neurons restores mEPSC amplitude to control levels (Control+DMSO: 16.15±0.49 pA ; 
Control+YM201636: 14.81±0.60 pA; Control+apilimod: 18.12±0.84 pA; 24h Bic+DMSO: 
12.58±0.50 pA ; 24h Bic+YM201636: 14.80±0.41 pA; 24h Bic+apilimod: 17.53±0.73 
pA). (one-way ANOVA, F(5,84)=9.33, p=4.3x10-7). (E) RepresentaƟ ve images of surface 
GluA2 and PSD95 staining with or without 50 μM bicuculline for 24 h. Neurons were 
live labeled with an amino-terminal anƟ body for the GluA2 subunit and fi xed. AŌ er 
permeabilizaƟ on, neuronal cultures were stained for PSD95. (F) Mean (±SEM) surface 
GluA2 intensity quanƟ fi ed in the fi rst 50 μm of dendrite relaƟ ve to the average control. 
The abundance of sGluA2 is decreased aŌ er 24 h treatment with bicuculline. The 
bicuculline induced decrease is restored to control levels with 1h of PIKfyve inhibiƟ on by 
either 1 μM apilimod or 2 μM YM201636 (Control: 100±2.29%; 24h Bic: 83.71±1.97; 24h 
Bic+1h YM201636: 95.41±2.27%; 24h Bic+1h apilimod: 96.94±2.68%; one-way ANOVA, 
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Figure 3-9. PIKfyve acƟ vity regulates AMPA receptor traﬃ  cking
(A) RepresentaƟ ve images of neurons co-transfected with pH-GluA2(Q) and mCherry. 
Neurons were incubated with DMSO or PIKfyve inhibitors for 1 h prior to live-confocal 
imaging. During imaging all soluƟ ons were conƟ nuously perfused at 32°C. (B) Mean 
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(±SEM) intensity of pH-GluA2(Q) relaƟ ve to the mean intensity of the fi rst 10 min of 
imaging. Once a stable baseline was obtained, HBS (0.2 mM Mg2+) was washed on for 
5 min followed by 5 min sƟ mulaƟ on with NMDA (20 μM NMDA, 10 μM Glycine, 0.2 
mM Mg2+). The fl uorescence of pH-GluA2(Q) is quenched by NMDA sƟ mulaƟ on. AŌ er 
NMDA sƟ mulaƟ on, normal HBS was conƟ nuously perfused for the remainder of the 
experiment. PIKfyve inhibiƟ on by either 1 μM apilimod or 2 μM YM201636 enhances the 
rate of pH-GluA2(Q) fl uorescence recovery. (C) RepresentaƟ ve images of neurons co-
transfected with pH-GluA1 and mCherry. (D) Mean (±SEM) intensity of pH-GluA1 relaƟ ve 
to the mean intensity of the fi rst 10 min of imaging. The fl uorescence of pH-GluA1 is 
strongly quenched by NMDA sƟ mulaƟ on, however the rate of recovery in control and 
PIKfyve inhibited neurons are indisƟ nguishable. (E) RepresentaƟ ve images of neurons 
stained for surface GluA2 (non-permeabilized) or internal GluA2 (aŌ er permeabilizaƟ on) 
with or without 1h incubaƟ on with 1 μM apilimod. (F) The raƟ o (±SEM) of surface to 
internal GluA2. The surface to internal raƟ o is reduced by 5 min NMDA sƟ mulaƟ on 
(20 μM NMDA, 10 μM Glycine, 0.2 mM Mg2+) in control neurons. IncubaƟ on with 1 
μM apilimod blocks the decrease in surface to internal raƟ o (raƟ o relaƟ ve to average 
baseline: Baseline: 1.0±0.02; 5 min NMDA: 0.86±0.03; 1h apilimod: 1.0±0.02; 1h 
apilimod + 5 min NMDA: 1.07±0.03; one-way ANOVA, F(3,101) = 14.68, p=5.26x10-8). (G) 
SchemaƟ c of experimental design and representaƟ ve images of surface GluA2 staining in 
dendrites. Neurons were sƟ mulated with NMDA (20 μM NMDA, 10 μM Glycine, 0.2 mM 
Mg2+) for 5 min and then indicated dishes were incubated with 1 μM apilimod for 10 min 
or 30 min at 37C. Cells were then fi xed and stained for surface GluA2. (H) Mean (±SEM) 
sGluA puncta integrated density (mean intensity x puncta size). RelaƟ ve to unsƟ mulated 
baseline sGluA2 puncta, in control neurons NMDA sƟ mulaƟ on transiently decreased 
in the integrated density of GluA2 puncta in dendrites at 10 min. When apilimod was 
applied aŌ er NMDA sƟ mulaƟ on, this decrease was blocked (Ɵ me aŌ er 5 min NMDA 
sƟ mulaƟ on: NMDA+10min: 78.43±5.46%; NMDA+30: 95.47±7.62%; NMDA+10 w/
apilimod: 100±6.47%; NMDA+30min w/apilimod: 98.84±6.47%; Kruskal-Wallis ANOVA, 
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 4-1. Loss of AMPAR acƟ vity rapidly enhances neural network acƟ vity 
A) RepresentaƟ ve extracellular recording of spontaneous acƟ on potenƟ als in pyramidal-
like neurons following AMPAR blockade for 3h with 40 μM CNQX or vehicle control.   B) 
Mean (±SEM) fold change in the number of acƟ on potenƟ als in a 2min period of high ac-
Ɵ vity.  High acƟ vity was defi ned as sustained fi ring for at least two min following at least 
10 sec of silence.  Following 3h AMPAR blockade, the number of APs increased (Control: 
1.00±0.196, CNQX3h: 1.73±0.313; t-test, t(32)= -2.06, p=0.048).  *p<0.05. n=number of 
cells. C) RepresentaƟ ve intracellular record of spontaneous excitatory synapƟ c currents 
in pyramidal-like neurons following AMPAR blockade for 3h with 40 μM CNQX or vehicle 
control (Vcom= -70 mV). D) Mean (±SEM) fold change in normalized charge-transfer in 
the fi rst 3min recorded.  Following 3h AMPAR blockade, the level of spontaneous acƟ vity 
greatly increases (Control: 1.00±0.45, CNQX3h: 7.39±3.28; t-test, t(11)= -2.47, p=0.031). 
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Figure 4-2. Increase in neural excitability following acƟ vity suppression 
A) RepresentaƟ ve acƟ on potenƟ al trains evoked by somaƟ c current injecƟ ons from rest-
ing membrane potenƟ al in pyramidal-like neurons in control neurons, following 24h and 
3h of acƟ vity suppression with 2 μM TTX or 40 μM CNQX. B) Mean (±SEM) number of 
acƟ on potenƟ als during 500 ms somaƟ c current injecƟ on.  AcƟ vity suppression for 24h 
decreases the current required to elicit acƟ on potenƟ als (Kruskal-Wallis, χ2(2,429)=9.22, 
p=0.01). *p<0.05 (Tukey-Kramer post hoc test). n=number of cells.  C) Mean (±SEM) 
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input resistance of neurons recorded in A-B aŌ er 24h (leŌ , in MΩ: Control-24h, 
128.36±9.90; TTX-24h, 151.82±7.56, CNQX-24h, 162.99±11.84, ANOVA, F(2,51)=2.90, 
p=0.064) or 3h (right, in MΩ: Control-3h, 128.53±9.03; TTX-3h, 124.81±6.11, CNQX-
3h, 131.36±6.11, ANOVA, F(2,50)=0.17, p=0.84) treatments. n=number of cells. D) 
Mean (±SEM) rheobase current aŌ er 24h (leŌ ) or 3h (right) treatments.  Suppression 
of acƟ vity by either 24h TTX or 24h CNQX signifi cantly lowered the current required 
to evoke at least one acƟ on potenƟ al (leŌ , in pA: Control-24h, 333.33±25.20; TTX-24h, 
235.0±18.17, CNQX-24h, 242.11±19.22, ANOVA, F(2,51)=6.49, p=0.0031).  Brief acƟ vity 
blockade did not impact rheobase current (right, in pA: Control-3h, 363.89±26.14; TTX-
3h, 361.90±26.37, CNQX-3h, 307.14±23.2, ANOVA, F(2,50)=1.33, p=0.27) treatments. 
*p<0.05 (Tukey-Kramer post hoc test). n=number of cells.
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Figure 4-3. AMPAR blockade causes a compensatory decrease in the threshold for ac-
Ɵ on potenƟ al generaƟ on 
A) RepresentaƟ ve acƟ on potenƟ al trains evoked by somaƟ c current injecƟ ons from 
resƟ ng membrane potenƟ al in pyramidal-like neurons treated with vehicle control, 40 
μM CNQX, 20 μM NBQX, or 20 μM APV. B) Mean (±SEM) number of acƟ on potenƟ als 
during 500 ms somaƟ c current injecƟ on. AMPAR antagonism by NBQX recapitulates 
the enhancement of excitability induced by CNQX.  Unlike AMPAR blockade, antago-
nism of NMDARs by 20 μM APV for just 3h decreases neural excitability (Kruskal-Wallis, 
χ2(3,3046)=60.26, p=5.18e-13). *p<0.05 (Tukey-Kramer post hoc test). n=number of 
cells. C) Mean acƟ on potenƟ al.  The fi rst acƟ on potenƟ al generated in control and CNQX 
treated neurons was averaged and overlaid.  The magnifi ed region (gray box) shows 
the iniƟ al rising phase of the acƟ on potenƟ al is iniƟ ated at a lower membrane poten-
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Ɵ al following AMPAR blockade.  n=number of cells. D) Mean (±SEM) resƟ ng membrane 
potenƟ al is unaﬀ ected by AMPAR blockade (in mV: Control, -65.34±0.38; CNQX-3h, 
-65.27±0.39, t-test, t(103)= -0.12, p=0.90). n=number of cells. E) Mean (±SEM) threshold 
for fi ring an acƟ on potenƟ al.  AMPAR blockade reduces the acƟ on potenƟ al threshold (in 
mV: Control, -35.98±0.63; CNQX-3h, -38.03±0.52, t-test, t(103)=2.47, p=0.015). *p<0.05. 
n=number of cells. F) Mean (±SEM) number of acƟ on potenƟ als normalized to the 
rheobase current. Despite the normalizaƟ on to rheobase, the mean number of acƟ on 
potenƟ als evoked is higher following AMPAR blockade compared to control (two-sample 
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Figure 4-4. Coordinated onset of compensaƟ on at synapses and in intrinsic excitability 
A) RepresentaƟ ve intracellular recording of synapƟ c currents in the presence of 100 nM 
ω-Conotoxin-GVIA (CTX) and 200 nM ω-Agatoxin-IVA (ATX) before (top) and aŌ er adding 
1 μM TTX (boƩ om). B) Individual EPSCs aligned in Ɵ me at the peak of the inward cur-
rent (light color) and the average EPSC (dark line) in the presence of CTX and ATX before 
(blue) and aŌ er adding 1 μM TTX (gray/black).  The scaled-to-peak overlays of each 
average EPSC are idenƟ cal.  Thus, suppression of evoked synapƟ c release CTX and ATX 
yields phenotypically similar EPSCs to miniature synapƟ c transmission recorded in the 
presence of TTX. C) Mean (±SEM) mEPSC amplitude.  Blockade of acƟ on potenƟ als by 1 
μM TTX does not decrease the amplitude of mEPSCs aŌ er suppression with CTX and ATX 
(in pA: CTX/ATX, 12.96±0.50, +TTX, 11.99±0.35, t-test, t(29)= -1.58, p=0.124). D) Mean 
(±SEM) mEPSC frequency.  Blockade of acƟ on potenƟ als by 1 μM TTX does not decrease 
192
the frequency of mEPSCs aŌ er suppression with CTX and ATX (in Hz: CTX/ATX, 2.74±0.32, 
+TTX, 2.07±0.35, t-test, t(29)= -1.60, p=0.121). E) RepresentaƟ ve recording of mEPSCs 
(top) and acƟ on potenƟ al trains evoked by somaƟ c current injecƟ ons (boƩ om) in neu-
rons treated with vehicle control or 40 μM CNQX for 1h. F) Mean (±SEM) mEPSC ampli-
tude of neurons treated with vehicle control or  40 μM CNQX for 1h.  AMPAR blockade 
rapidly increases mEPSC amplitude (in pA: control, 11.98±0.46, CNQX-1h, 15.56±1.09, 
t-test, t(23)= -3.11, p=0.0049). *p<0.05. n=number of cells. F) Mean (±SEM) mEPSC fre-
quency of neurons treated with vehicle control or  40 μM CNQX for 1h.  AMPAR block-
ade rapidly increases mEPSC frequency (in Hz: control, 2.26±0.36, CNQX-1h, 6.59±1.76, 
t-test, t(23)= -2.51, p=0.020). *p<0.05. n=number of cells. G) Mean (±SEM) maximum 
number of acƟ on potenƟ als evoked by somaƟ c current injecƟ ons in neuron treated with 
vehicle control or  40 μM CNQX for 1h.  AMPAR blockade rapidly increases the number 
of evoked acƟ on potenƟ als (number of acƟ on potenƟ als in 500 ms: control, 4.31±0.47, 
CNQX-1h, 7.5±1.12, t-test, t(23)= -2.69, p=0.013). *p<0.05. n=number of cells.  H) Mean 
(±SEM) number of acƟ on potenƟ als evoked with indicated current injecƟ ons.  AMPAR 
blockade rapidly increases the intrinsic excitability of neurons in 1h (two-sample K-S test, 
D=0.19, p=0.020). *p<0.05. n=number of neurons.
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Figure 4-5. Protein synthesis is required for rapid compensatory enhancement of in-
trinsic neural excitability 
A) RepresentaƟ ve intracellular recordings of acƟ on potenƟ al trains elicited by somaƟ c 
current injecƟ ons.  Neurons treated with the protein synthesis inhibitor emeƟ ne (25 μM) 
for 30 min prior to and during AMPAR blockade with 40 uM CNQX for 1h were compared 
to either 25 μM emeƟ ne (90 min total) or 40 μM CNQX (1h) alone. B) Mean (±SEM) 
number of acƟ on potenƟ als at indicated current steps.  The increase in number of acƟ on 
potenƟ als elicited aŌ er 1h AMPAR blockade is blocked when protein synthesis is inhib-
ited (25 μM emeƟ ne) for 30 min prior to and during AMPAR blockade  (two-sample K-S 
test, D=0.18, p=4.8e-06). *signifi cantly diﬀ erent from CNQX (p<0.05).  C) RepresentaƟ ve 
intracellular recordings of acƟ on potenƟ al trains elicited by somaƟ c current injecƟ ons. 
The intrinsic excitability of neurons treated with the protein synthesis inhibitor aniso-
mycin (40 μM) for 30 min prior to and during AMPAR blockade with 40 uM CNQX for 3h 
compared to both 40 μM anisomycin (3.5h total) or 40 μM CNQX (3h) alone.  D) Mean 
(±SEM) number of acƟ on potenƟ als at indicated current steps.  The increase in number 
of acƟ on potenƟ als elicited aŌ er 1h AMPAR blockade is blocked when protein synthe-
sis is inhibited (40 μM anisomycin) for 30 min prior to and during AMPAR blockade  
(two-sample K-S test, D=0.16, p=2.7e-06). *signifi cantly diﬀ erent from CNQX (p<0.05). 
n= number of neurons.  E) Mean (±SEM) number of acƟ on potenƟ als at indicated cur-
rent steps.  InhibiƟ on of protein synthesis for 3.5h with 40 μM anisomycin signifi cantly 
changed the distribuƟ on of acƟ on potenƟ als evoked by current injecƟ ons compared to 
control-3h, suggesƟ ng that protein synthesis alone can decrease excitability (Kruskal-
Wallis test, χ2(3,1671)=41.45, p=5.2e-09, Tukey-Kramer post hoc test).  F) Mean (±SEM) 
number of acƟ on potenƟ als at indicated current steps.  Scavenging of endogenous BDNF 
(1 μg/mL TrkB-fc) for 30 min prior to and during 3h AMPAR blockade does not block ho-
meostaƟ c enhancement of intrinsic excitability (two-sample K-S test, D=0.033, p=0.997, 
not signifi cant). G) Mean (±SEM) number of acƟ on potenƟ als at indicated current steps.  
InhibiƟ on of mTORC1 (100 nM rapamycin) for 30 min prior to and during 3h AMPAR 
blockade does not block homeostaƟ c enhancement of intrinsic excitability (two-sample 


























































































































Figure 4-6. AMPAR blockade enhances the abundance of NaV1.1 and NaV1.2 in the axon 
iniƟ al segment 
A) RepresentaƟ ve images of neurons stained for NaV1.1 (green), MAP2 (red) and an-
kyrin (blue) aŌ er vehicle control, 40 μM CNQX (3h), 40 μM anisomycin(3,5) plus 40 
μM CNQX (3h), or 40 μM anisomycin (3.5h).  B) The axon iniƟ al segments indicated by 
white boxes in (A) with the channels separated.  C) Mean (±SEM) NaV1.1 intensity in the 
axon iniƟ al segment normalized to control.  AMPAR blockade signifi cantly increases the 
abundance of NaV1.1 in the axon iniƟ al segment (neurite colabeled with ankyrin) and 
this increase in blocked by pretreatment with protein synthesis inhibitors (in percent 
of control: control,100.00±4.081, 3h CNQX, 123.95±7.92, Anisomycin(3.5h)+CNQX(3h), 
100.51±5.66, Anisomycin(3.5h), 97.40±5.92, ANOVA, F(3,117)=4.25, p=0.0068). *sig-
nifi cantly diﬀ erent from control (p<0.05). n= number of axons. D) Mean (±SEM) NaV1.1 
intensity in the soma normalized to control.  AMPAR blockade does not impact somaƟ c 
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levels of NaV1.1  (in percent of control: control, 100.00±5.58, 3h CNQX, 93.66±3.12, 
Anisomycin(3.5h)+CNQX(3h), 89.95±4.13, Anisomycin(3.5h), 93.57±3.14, ANOVA, 
F(3,117)=1.03, p=0.38). n= number of somas. E) RepresentaƟ ve images of neurons 
stained for NaV1.2, MAP2 and ankyrin aŌ er vehicle control, 40 μM CNQX (3h), 40 μM 
anisomycin(3,5) plus 40 μM CNQX (3h), or 40 μM anisomycin (3.5h).  F) The axon iniƟ al 
segments indicated by white boxes in (E) with the channels separated. G) Mean (±SEM) 
NaV1.2 intensity in the axon iniƟ al segment normalized to control.  AMPAR blockade 
signifi cantly increases the abundance of NaV1.2 in the axon iniƟ al segment (neurite 
colabeled with ankyrin) and this increase in blocked by pretreatment with protein syn-
thesis inhibitors (in percent of control: control, 100.00±9.31, 3h CNQX, 138.44±10.28, 
Anisomycin(3.5h)+CNQX(3h), 101.71±11.42, Anisomycin(3.5h), 91.34±9.87, ANOVA, 
F(3,161)=4.13, p=0.0074). *signifi cantly diﬀ erent from control (p<0.05). n= number 
of axons. H) Mean (±SEM) NaV1.2 intensity in the soma normalized to control.  AM-
PAR blockade does not impact somaƟ c levels of NaV1.2  (in percent of control: con-
trol, 100.00±0.93, 3h CNQX, 102.21±0.85, Anisomycin(3.5h)+CNQX(3h), 105.66±1.65, 
Anisomycin(3.5h), 101.89±0.57, ANOVA, F(3,159)=4.89, p=0.0028). *signifi cantly dif-
ferent from control (p<0.05). n= number of somas. (not shown) AMPAR blockade does 
not impact dendriƟ c levels of NaV1.2 (in percent of control: control, 100.00±3.02, 3h 
CNQX,102.26±4.33, t-test, t(120)= -0.4221, p=0.67). ◊Data were collected and analyzed 

































































































































































































































































































































































































































































Figure A.1 - Neuronal expression of the PI(3,5)P2 reporter (eGFP-ML1N*2) is found in 
axons
Cultured hippocampal neurons were transfected on DIV20 with 1 μg eGFP-ML1N*2 
plasmid DNA and 0.5 μg synaptophysin-mCherry by the calcium phosphate transfecƟ on 
protocol and incubated for 24h in the 37C, 5%C02 incubator.  Neurons expressing both 
plasmids were imaged live on the confocal microscope.  The extracellular soluƟ on 
contained: 119 mM NaCl, 5 mM KCl, 2 mM CaCl2, 2 mM MgCl2, 30 mM glucose, 10 mM 
HEPES, pH 7.4.  Z-projected,   median fi ltered (0.5 pixel), background subtracted images 
are shown. 5 axons of 5 diﬀ erent neurons were analyzed.  Most synaptophysin-mCherry 
posiƟ ve puncta (likely presynapƟ c terminals) also have eGFP-ML1N*2; these results 











































Figure A-2. InhibiƟ on of PIKfyve increases Lamp1 compartment size and decreases the 
colocalizaƟ on of the PI(3,5)P2 reporter with lysosomes
Cultured hippocampal neurons were transfected on DIV19 with 1 μg mCherry-ML1N*2 
plasmid DNA and 1.0 μg Lamp1-eGFP by the calcium phosphate transfecƟ on and incu-
bated for 24h in the 37C, 5% C02.  AŌ er 24h, a subset of dishes were treated with 2μM 
YM201636 for an addiƟ on 1 or 24h.  Neurons expressing both plasmids were imaged live 
on the confocal microscope.  The extracellular soluƟ on contained: 119 mM NaCl, 5 mM 
KCl, 2 mM CaCl2, 2 mM MgCl2, 30 mM glucose, 10 mM HEPES, pH 7.4.  Z-projected im-
ages are shown. A) RepresentaƟ ve image of a control neuron (one experiment, 10 cells). 
B) RepresentaƟ ve image of a neuron treated with 2μM YM201636 for 1 or 24 hours prior 
to imaging (one experiment, 7-9 cells per Ɵ mepoint).  PIKfyve inhibiƟ on increases the 
size of the Lamp1 compartments within 1h and decreases the colocalizaƟ on of Lamp1 
and mCh-ML1N*2.  AŌ er PIKfyve inhibiƟ on some punctate signal is sƟ ll apparent in the 
mCh-ML1N*2 channel; these puncta appear to be inside Lamp1 compartments and thus 



















Figure A-3. HomeostaƟ c responses to changes in acƟ vity maintain neural networks 
within a dynamic range  
Changes in the strength postsynapƟ c dendriƟ c spine – or sensiƟ vity of the postsynapƟ c 
compartment to neurotransmiƩ er – can drive changes in the level neural acƟ vity.  With-
out compensatory regulaƟ on of the strength of the synapse, subsequent bouts of synap-
Ɵ c plasƟ city could eventually lead to saturaƟ on of the network, which would leave the 










































Figure A-4. Vac14 knockout neurons express normal long-term depression
A) RepresentaƟ ve intracellular recordings of mEPSCs from DIV 14 wild-type and Vac14-/- 
neurons under basal condiƟ ons (top traces) and 30-90 min aŌ er inducƟ on of long-term 
depression (boƩ om traces). Long-term depression was induced by sƟ mulaƟ ng neurons 
for 5 min (followed by returning neurons to reserved media for 30 min) with the fol-
lowing soluƟ on: 20 μM NMDA, 1 μM glycine, 25 mM HEPES, 120 mM NaCl, 5 mM KCl, 1 
mM CaCl2, 0.2 mM MgCl2, 30 mM D-glucose, pH 7.4. The extracellular recording soluƟ on 
contained HBS: 119 mM NaCl, 5 mM KCl, 2 mM CaCl2, 2 mM MgCl2, 30 mM Glucose, 10 
mM HEPES, pH 7.4 plus 10 μM bicuculline (Tocris, O130) and 1 μM TTX (EMD Bioscience, 
554412). The internal pipeƩ e soluƟ on contained: 100 mM cesium gluconate, 0.2 mM 
EGTA, 5 mM MgCl2, 40 mM HEPES, 2 mM Mg-ATP, 0.3 mM Li-GTP, 1 mM QX-314 (pH 
7.2). PipeƩ e resistance ranged from 3-5 MΩ. Neurons with a pyramidal-like morphol-
ogy were targeted for analysis. For Vac14-/-  neurons, neurons with minimal vacuolaƟ on 
were targeted for analysis. Neurons were voltage clamped at -70 mV, and series resis-
tance was not compensated. mEPSC amplitude and frequency were analyzed oﬄ  ine 
using Minianalysis (SynaptosoŌ ). Cultured neurons with a pyramidal-like morphology 
were voltage-clamped at –70 mV. B) Mean (±SEM) mEPSC amplitude.  InducƟ on of LTD 
reduces mEPSC amplitude similarly in both wild-type and Vac14-/-  neurons (Wild-type: 
14.32±0.60 pA, n=10. Wild-type+cLTD: 11.67±0.41 pA, n=9. Vac14-/- : 16.87±0.77 pA, 
n=10. Vac14-/- +cLTD: 12.17±0.49 pA, n=14. ANOVA, F(3,39)=15.93, p=6.47e-07, Tukey-
Kramer post hoc).*signifi cantly diﬀ erent (p<0.05). C) Mean (±SEM) mEPSC frequency. 
InducƟ on of LTD does not signifi cantly reduce the frequency of events (Wild-type: 
1.22±0.34 Hz, n=10. Wild-type+cLTD: 0.93±0.24 Hz, n=9. Vac14-/- : 1.56±0.34 Hz, n=10. 












































































































































































































































sEPSC - spontaneous excitatory postsynaptic current
mEPSC - miniature excitatory postsynaptic current
+Tetrodotoxin 
(blocks action potential initiation)
Figure A-6. Comparison of miniature and spontaneous postsynapƟ c currents
Cultured hippocampal neurons form spontaneously acƟ ve networks that form funcƟ on 
synapƟ c connecƟ ons.  In response to an acƟ on potenƟ al arrival in the presynapƟ c 
terminal, calcium infl ux increases and drives vesicle fusion with the plasma membrane.  
The fusion of the vesicle allows for neurotransmiƩ er to release into the synapse and 
acƟ vate postsynapƟ c receptors.  These events can be observed in the postsynapƟ c 
neurons by whole-cell voltage clamp and are called “spontaneous” excitatory 
postsynapƟ c currents (sEPSC).  The spontaneous acƟ vity can be prevented by applicaƟ on 
of tetrodotoxin (TTX) which is an antagonist of voltage-gated sodium channels.  Voltage-
gated sodium channels are responsible for the iniƟ aƟ on of acƟ on potenƟ als, thus 
blocking these channels prevents acƟ on potenƟ al fi ring.  In the absence of acƟ on 
potenƟ als, seemingly random vesicle fusion events conƟ nue to occur.  These synapƟ c 
events are called miniature EPSC s (mEPSC).  As each event refl ect the release of a 
quantum of neurotransmiƩ er.
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Mouse cultured hippocampal neurons (DIV21)
Mouse cultured hippocampal neurons
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Mouse cultured hippocampal neurons
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Figure A-7. Images of neurons aŌ er PIKfyve knockdown
A) Diﬀ erenƟ al Interference Contrast (DIC) image of mature mouse cultured hippocampal 
neurons (DIV21). B) Rat hippocampal cultured neurons appear similar to (A) at DIV21. 
C) Vacuoles (arrowhead) are apparent in neurons infected with PIKfyve shRNA lenƟ virus 
aŌ er 7 days.  Vacuoles began to appear 4 days aŌ er infecƟ on. D) InfecƟ on with non-tar-
geƟ ng shRNA lenƟ virus did not cause vacuoles to form and was generally well tolerated. 




Figure A-8. Citrine-PIKfyve distribuƟ on changes aŌ er chronic hyperexcitaƟ on
A) To gain further insight into the subcellular sites of PI(3,5)P2 synthesis following 
chronic hyperacƟ vaƟ on, we examined the localizaƟ on of fl uorescently tagged PIKfyve 
(Citrine-PIKfyve) and found it was more abundant in dendrites and the soma aŌ er 24h 
Bic (A-B).  Notably, the increase iwas largely driven by increased diﬀ use fl uorescence.  
Under basal condiƟ ons Citrine-PIKfyve is punctate and concentrated in the cell body (A).  
Following Bic treatment, Citrine-PIKfyve becomes both more diﬀ use (C-D).  The increase 
in diﬀ use signal is unexpected since the PIKfyve substrate is embedded in membranes.  
One possibility is that with hyperacƟ vity the compartments with which PIKfyve localizes 
became too small to resolve at the level of light microscope.  The development of 
an anƟ body for acƟ vated PIKfyve would be required to determine the membrane 
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Figure A-9. InhibiƟ on of PIKfyve in wild-type MEFs by 1 μM apilimod
Inhibition in mouse primary fibroblasts by 1 μM apilimod for the specified times (2.5, 5, 
10, 30 and120 mins) results in a rapid depletion of PI(3,5)P2 and PI5P (n=3). Note, the 
increase in PI3P during PIKfyve inhibition is likely due to accumulation of the pool of 
PI3P that is the precursor for PI(3,5)P2 synthesis. These experiments were performed by 
Yanling Zhang and reanalyzed here for PI(3,4,5)P3 levels, which are stable with apilimod.  
Note, for each lipid, except PI(3,4,5)P3, PIKfyve inhibition  impacts the levels similarly 
(compare to Figure A-10).
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Figure A-10. InhibiƟ on of PIKfyve in wild-type MEFs by 1.6 μM YM201636 
Inhibition in mouse primary fibroblasts by 1.6 μM YM201636 for the specified times (2.5, 
5, 7.5, 10, 20 and 60 mins) results in a rapid depletion of PI(3,5)P2 and PI5P (n=4). Note, 
the increase in the level of PI3P during PIKfyve inhibition is likely due to accumulation of 
the pool of PI3P that is the precursor for PI(3,5)P2 synthesis.  The rapid decrease in the 
level of PI(3,4,5)P3 observed following PIKfyve inhibition in as little as 5 min is likely due 
to off-target effects of the inhibitor. These experiments were performed by Sergey Zolov 
and portions published previously in Zolov et al. (2012).
Zolov SN, Bridges D, Zhang Y, Lee WW, et al., & Weisman LS. 2012. In vivo, Pikfyve gener-
ates PI(3,5)P2, which serves as both a signaling lipid and the major precursor for PI5P. 


































































































































Α-acƟ nin2 TTX BIC Ehlers, 2003
Arc TTX BIC Shepherd et al., 2006
ARMS/Kidins220 TTX BIC Cortes et al., 2007
AKAP79/150 TTX BIC Ehlers, 2003
Β3 Integrin TTX BIC Cingolani et al., 2008
αCaMKII
TTX BIC Thiagarajan et al., 2002
AP-5 or NBQX Thiagarajan et al., 2002
TTX BIC Ehlers, 2003
βCaMKII
TTX or NBQX BIC Thiagarajan et al., 2002
AP-5 Thiagarajan et al., 2002
TTX BIC Ehlers, 2003
CaMKII-T286P TTX BIC Ehlers, 2003
p-EphA4 BIC Fu et al., 2011
EphA4 BIC Peng et al., 2013
GluA1
APV/CNQX PTX/STRYCH O'Brien et al., 1998
TTX Galvan et al., 2003
NBQX Thiagarajan et al., 2005
AP-5 Thiagarajan et al., 2005
TTX BIC Shepherd et al., 2006
TTX BIC Hou et al., 2008
Kir2.1 (PRE) Hou et al., 2008
TTX BIC Hu et al., 2010
TTX BIC Jakawich et al., 2010
TTX BIC Anggono et al., 2011
BIC Fu et al., 2011
PTX Lee et al., 2011
TTX BIC Shin et al., 2012
BIC Peng et al., 2013
BIC Siddoway et al., 2013
Appendix  J 
Table 4. HomeostaƟ c changes in protein levels or acƟ vity following prolonged changes 
in neural acƟ vity (>12h; slow homeostaƟ c synapƟ c plasƟ city)
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GluA2
APV/CNQX PTX/STRYCH O'Brien et al., 1998
NBQX Thiagarajan et al., 2005
TTX BIC Cingolani et al., 2008
Kir2.1 (PRE) Hou et al., 2008
TTX BIC Hu et al., 2010
TTX BIC Jakawich et al., 2010
TTX BIC Anggono et al., 2011
PTX Lee et al., 2011
TTX BIC Shin et al., 2012
TTX AlƟ mimi and Stellwagen, 2013
BIC Peng et al., 2013
BIC Siddoway et al., 2013
GKAP TTX BIC Ehlers, 2003TTX BIC Shin et al., 2012
GRIP Kir2.1 (PRE) Hou et al., 2008
HCN1 TTX Arimitsu et al., 2009
Homer TTX BIC Ehlers, 2003
Homer1a TTX BIC Hu et al., 2010
I-2 p-S43 TTX BIC Siddoway et al., 2013
mGluR1α TTX BIC Ehlers, 2003
Myosin Va TTX BIC Ehlers, 2003
nNOS TTX BIC Ehlers, 2003
NR1, NR2B
TTX BIC Ehlers, 2003
TTX Galvan et al., 2003
BIC Casanova et al., 2013
NR2A TTX BIC Ehlers, 2003BIC Casanova et al., 2013
NSF TTX BIC Ehlers, 2003
PICK1 TTX BIC Anggono et al., 2011BIC Peng et al., 2013
PKA-cat TTX BIC Ehlers, 2003
PKA-RIIβ TTX BIC Ehlers, 2003
PKCβ TTX BIC Ehlers, 2003
PKCε TTX BIC Ehlers, 2003
PKCγ TTX BIC Ehlers, 2003
Plk2 (SNK) PTX Pak and Sheng, 2003PTX Seeburg and Sheng, 2008
PP1 TTX BIC Ehlers, 2003
PSD95 
(hippocampus)
Kir2.1 (pre) Hou et al., 2008
TTX BIC Jakawich et al., 2010
BIC Peng et al., 2013
PTX Lee et al., 2011
PTX Pak and Sheng, 2003
TTX BIC Shin et al., 2012
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PSD95 (corƟ cal)
TTX BIC Fu et al., 2011
BIC Fu et al., 2011
TTX or DNQX PTX OR BIC Sun and Turrigiano, 2011
PSD93
TTX BIC Ehlers, 2003
TTX or DNQX PTX OR BIC Sun and Turrigiano, 2011
TTX BIC Shin et al., 2012
AcƟ ve Rap2 PTX Lee et al., 2011
AcƟ ve Ras PTX Lee et al., 2011
PSD93 TTX BIC Ehlers, 2003
Sap102 TTX BIC Ehlers, 2003TTX or DNQX PTX OR BIC Sun and Turrigiano, 2011
Shank TTX BIC Ehlers, 2003
Spinophilin TTX BIC Ehlers, 2003
SynGAP TTX BIC Ehlers, 2003
Tubulin TTX BIC Ehlers, 2003
Rap GAP (SPAR) PTX Pak and Sheng, 2003PTX Lee et al., 2011
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